Affinity Asset Advisors’s Medicus Sciences Acquisition Corp. Unit MSACU Stock Holding History

Affinity Asset Advisors’s Portfolio MSACU Stock Details MSACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-300,000	Closed	-$2.96M	–	87
2021 Q1	$2.96M	Buy	+300,000	New	+$3.05M	1%	25

Other funds holding MSACU

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Affinity Asset Advisors's MSACU Position: Q2 2021 in Review

Affinity Asset Advisors sold out of Medicus Sciences Acquisition Corp. Unit (MSACU) in Q2 2021, closing a stake of 300,000 shares — an estimated $2.96M sold.

Affinity Asset Advisors first reported a position in MSACU in Q1 2021 and held it in 1 quarter. The position peaked at $2.96M in Q1 2021. 1 fund tracked by Wall St. Rank holds MSACU as of Q2 2021.

Affinity Asset Advisors reported no remaining Medicus Sciences Acquisition Corp. Unit position as of Q2 2021 after selling out during the quarter.
Affinity Asset Advisors sold 300,000 Medicus Sciences Acquisition Corp. Unit shares in Q2 2021, an estimated $2.96M.
Affinity Asset Advisors first reported a position in Medicus Sciences Acquisition Corp. Unit in Q1 2021 and held it in 1 quarter.
Affinity Asset Advisors's Medicus Sciences Acquisition Corp. Unit position peaked at $2.96M in Q1 2021.
1 fund tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Unit as of Q2 2021.

Based on Affinity Asset Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.